Moser M - Search Results

1

BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis.

Heinke J, Wehofsits L, Zhou Q, Zoeller C, Baar KM, Helbing T, Laib A, Augustin H, Bode C, Patterson C, Moser M. Heinke J, et al. Among authors: moser m. Circ Res. 2008 Oct 10;103(8):804-12. doi: 10.1161/CIRCRESAHA.108.178434. Epub 2008 Sep 11. Circ Res. 2008. PMID: 18787191

2

Clinical trial results with a new plasminogen activator.

Bode C, Peter K, Moser M, Smalling RW, Weaver WD. Bode C, et al. Among authors: moser m. Eur Heart J. 1997 Dec;18 Suppl F:F17-21. doi: 10.1093/eurheartj/18.suppl_f.17. Eur Heart J. 1997. PMID: 9447336 Review.

3

Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18).

Peter K, Schwarz M, Conradt C, Nordt T, Moser M, Kübler W, Bode C. Peter K, et al. Among authors: moser m. Circulation. 1999 Oct 5;100(14):1533-9. doi: 10.1161/01.cir.100.14.1533. Circulation. 1999. PMID: 10510057

4

Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase.

Moser M, Nordt T, Peter K, Ruef J, Kohler B, Schmittner M, Smalling R, Kübler W, Bode C. Moser M, et al. Circulation. 1999 Nov 2;100(18):1858-64. doi: 10.1161/01.cir.100.18.1858. Circulation. 1999. PMID: 10545429 Clinical Trial.

5

Pharmacokinetics and pharmacodynamics of lanoteplase (n-PA).

Nordt TK, Moser M, Kohler B, Kübler W, Bode C. Nordt TK, et al. Among authors: moser m. Thromb Haemost. 1999 Sep;82 Suppl 1:121-3. Thromb Haemost. 1999. PMID: 10695501 Review.

6

Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine.

Peter K, Kohler B, Straub A, Ruef J, Moser M, Nordt T, Olschewski M, Ohman ME, Kübler W, Bode C. Peter K, et al. Among authors: moser m. Circulation. 2000 Sep 26;102(13):1490-6. doi: 10.1161/01.cir.102.13.1490. Circulation. 2000. PMID: 11004138

7

4-hydroxynonenal induces apoptosis, NF-kappaB-activation and formation of 8-isoprostane in vascular smooth muscle cells.

Ruef J, Moser M, Bode C, Kübler W, Runge MS. Ruef J, et al. Among authors: moser m. Basic Res Cardiol. 2001 Apr;96(2):143-50. doi: 10.1007/s003950170064. Basic Res Cardiol. 2001. PMID: 11327332

8

Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells.

Ruef J, Moser M, Kübler W, Bode C. Ruef J, et al. Among authors: moser m. Cardiovasc Pathol. 2001 Nov-Dec;10(6):311-5. doi: 10.1016/s1054-8807(01)00095-3. Cardiovasc Pathol. 2001. PMID: 11755377

9

Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates.

Moser M, Bertram U, Peter K, Bode C, Ruef J. Moser M, et al. J Cardiovasc Pharmacol. 2003 Apr;41(4):586-92. doi: 10.1097/00005344-200304000-00011. J Cardiovasc Pharmacol. 2003. PMID: 12658060

10

Thrombin and vascular development: a sticky subject.

Moser M, Patterson C. Moser M, et al. Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):922-30. doi: 10.1161/01.ATV.0000065390.43710.F2. Epub 2003 Mar 6. Arterioscler Thromb Vasc Biol. 2003. PMID: 12807713 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,773 results

Search Page

Filters